SCHEMBL7789771

SCHEMBL7789771

O=C(O)COc1cc2c(c(Cl)c1Cl)C1=CC(=O)CC[C@]1(CCO)C2

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 3/20 0.47
MEN1 O00255 3/20 0.47
KMT2A Q03164 3/20 0.47
CYP3A4 P08684 2/20 0.47
CYP2C9 P11712 2/20 0.47
LMNA P02545 2/20 0.47
BLM P54132 2/20 0.47
TSHR P16473 2/20 0.47
HIF1A Q16665 1/20 0.47
NFKB1 P19838 1/20 0.45
MAPK1 P28482 1/20 0.45
GMNN O75496 1/20 0.45
NPSR1 Q6W5P4 1/20 0.45
ESR2 Q92731 5/20 0.39
ESR1 P03372 3/20 0.39
ALOX15 P16050 1/20 0.38
RECQL P46063 1/20 0.38
GRM2 Q14416 2/20 0.33
PTGDR2 Q9Y5Y4 2/20 0.32
PTGDR Q13258 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7789773 1.00 HSD17B10 (0.47) HSD17B10MEN1KMT2ACYP3A4CYP2C9
SCHEMBL10656876 0.92 HSD17B10 (0.47) HSD17B10MEN1KMT2ACYP3A4CYP2C9
SCHEMBL10660654 0.92 HSD17B10 (0.48) HSD17B10MEN1KMT2ACYP3A4CYP2C9
SCHEMBL6572282 0.91 MEN1 (0.51) HSD17B10MEN1KMT2ACYP3A4CYP2C9
SCHEMBL1888816 0.91 MEN1 (0.51) HSD17B10MEN1KMT2ACYP3A4CYP2C9
SCHEMBL10738974 0.90 MEN1 (0.50) HSD17B10MEN1KMT2ACYP3A4CYP2C9
Potassium SCHEMBL10738982 0.90 MEN1 (0.50) HSD17B10MEN1KMT2ACYP3A4CYP2C9
SCHEMBL11111293 0.89 HSD17B10 (0.56) HSD17B10MEN1KMT2ACYP3A4CYP2C9
SCHEMBL11109377 0.89 MEN1 (0.50) HSD17B10MEN1KMT2ACYP3A4CYP2C9
SCHEMBL11264415 0.89 MEN1 (0.50) HSD17B10MEN1KMT2ACYP3A4CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6251898-B1 Medical use of fluorenone derivatives for treating and preventing brain and spinal injury QUESTCOR PHARMACEUTICALS, INC. 2001-06-26 US disclosed
WO-2001014334-A1 FLUORENONE COMPOUNDS WITH MODIFIED 7-POSITION SUBSTITUENTS FOR TREATING AND PREVENTING BRAIN AND SPINAL INJURY QUESTCOR PHARMACEUTICALS, INC. (US) 2001-03-01 WO disclosed